title: Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients.
authors.forename: K
authors.initials: K
authors.lastname: Zouaoui Boudjeltia
authors.forename: G
authors.initials: G
authors.lastname: Tragas
authors.forename: S
authors.initials: S
authors.lastname: Babar
authors.forename: A
authors.initials: A
authors.lastname: Moscariello
authors.forename: V
authors.initials: V
authors.lastname: Nuyens
authors.forename: P
authors.initials: P
authors.lastname: Van Antwerpen
authors.forename: O
authors.initials: O
authors.lastname: Gilbert
authors.forename: J
authors.initials: J
authors.lastname: Ducobu
authors.forename: D
authors.initials: D
authors.lastname: Brohee
authors.forename: M
authors.initials: M
authors.lastname: Vanhaeverbeek
authors.forename: A
authors.initials: A
authors.lastname: Van Meerhaeghe
mesh_terms: D008078:Cholesterol, LDL / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000628:therapy*; D016209:Interleukin-8 / Q000097:blood; D018384:Oxidative Stress; D010100:Oxygen / Q000378:metabolism*; D010102:Oxygen Inhalation Therapy / Q000379:methods*; D009195:Peroxidase / Q000378:metabolism*; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000628:therapy*; D016212:Transforming Growth Factor beta / Q000097:blood; D016896:Treatment Outcome
chemical_list: D008078:Cholesterol, LDL; D016209:Interleukin-8; D016212:Transforming Growth Factor beta; D009195:Peroxidase; D010100:Oxygen